Pentarane A
Overview[edit]
Pentarane A is a synthetic progestin, a type of hormone that mimics the effects of progesterone in the body. It is part of the steroid class of compounds and is used in various medical applications, particularly in hormonal contraception and hormone replacement therapy.
Chemical Structure[edit]

Pentarane A is characterized by its unique chemical structure, which includes a cyclopentane ring fused to a steroid backbone. This structure is responsible for its biological activity and its ability to bind to progesterone receptors.
Mechanism of Action[edit]
Pentarane A functions by binding to progesterone receptors in target tissues, such as the uterus, mammary glands, and brain. This binding leads to the activation of specific gene expression pathways that mediate the physiological effects of progesterone, including the regulation of the menstrual cycle, maintenance of pregnancy, and modulation of immune response.
Clinical Uses[edit]
Pentarane A is primarily used in the following clinical contexts:
- Hormonal Contraception: As a component of oral contraceptives, Pentarane A helps prevent ovulation and alters the endometrium to prevent implantation of a fertilized egg.
- Hormone Replacement Therapy (HRT): In postmenopausal women, Pentarane A is used to alleviate symptoms associated with menopause and to reduce the risk of osteoporosis.
Side Effects[edit]
Like other progestins, Pentarane A may cause side effects, including:
Patients are advised to consult with their healthcare provider to manage any adverse effects.
Pharmacokinetics[edit]
Pentarane A is administered orally and is absorbed through the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, which affects its bioavailability. The metabolites are excreted primarily through the urine.
Research and Development[edit]
Ongoing research is exploring the potential of Pentarane A in treating other conditions, such as endometriosis and uterine fibroids. Its role in cancer therapy is also being investigated, particularly in breast cancer and endometrial cancer.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian